Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2014

Cho H, Herzka T, Zheng W, Qi J, Wilkinson JE, Bradner JE, et al. RapidCaP, a novel GEM model for metastatic prostate cancer analysis and therapy, reveals myc as a driver of Pten-mutant metastasis. Cancer Discov. 2014;4(3):318-33.

Gordon J, Udeh U, Doobay K, Magro C, Wildman H, Davids M, et al. Imatinib mesylate (Gleevec) in the treatment of diffuse cutaneous systemic sclerosis: results of a 24-month open label, extension phase, single-centre trial. Clin Exp Rheumatol. 2014;32(6 Suppl 86):S-189-93.

Piccaluga PP, Rossi M, Agostinelli C, Ricci F, Gazzola A, Righi S, et al. Platelet-derived growth factor alpha mediates the proliferation of peripheral T-cell lymphoma cells via an autocrine regulatory pathway. Leukemia. 2014;28(8):1687-97.

Patel RG, Purwada A, Cerchietti L, Inghirami G, Melnick A, Gaharwar AK, et al. Microscale Bioadhesive Hydrogel Arrays for Cell Engineering Applications. Cell Mol Bioeng. 2014;7(3):394-408.

Santos PP, Oliveira F, Ferreira VC, Polegato BF, Roscani MG, Fernandes AA, et al. The role of lipotoxicity in smoke cardiomyopathy. PLoS One. 2014;9(12):e113739.

Westblade LF, Haghi N, Pritt BS, Edelman M. Photo Quiz. Appendicitis in a 4-year-old child. Clin Infect Dis. 2014;58(3):400, 442-3.

Odejide O, Weigert O, Lane AA, Toscano D, Lunning MA, Kopp N, et al. A targeted mutational landscape of angioimmunoblastic T-cell lymphoma. Blood. 2014;123(9):1293-6.

Li W, Cooper J, Zhou L, Yang C, Erdjument-Bromage H, Zagzag D, et al. Merlin/NF2 loss-driven tumorigenesis linked to CRL4(DCAF1)-mediated inhibition of the hippo pathway kinases Lats1 and 2 in the nucleus. Cancer Cell. 2014;26(1):48-60.

Chen X, Iliopoulos D, Zhang Q, Tang Q, Greenblatt MB, Hatziapostolou M, et al. XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway. Nature. 2014;508(7494):103-107.

Riester M, Werner L, Bellmunt J, Selvarajah S, Guancial EA, Weir BA, et al. Integrative analysis of 1q23.3 copy-number gain in metastatic urothelial carcinoma. Clin Cancer Res. 2014;20(7):1873-83.